Brief: Chinook Receives Rare Pediatric Disease Designation From U.S. Food And Drug Administration For CHK-336 For Treatment Of Primary Hyperoxaluria

Chinook Therapeutics

02/02/2021 13:26

Feb 2 (Reuters) - Chinook Therapeutics Inc  KDNY.O :
    * CHINOOK RECEIVES RARE PEDIATRIC DISEASE DESIGNATION FROM
U.S.
FOOD AND DRUG ADMINISTRATION FOR CHK-336 FOR TREATMENT OF
PRIMARY HYPEROXALURIA

Source text for Eikon:  ID:nGNX6sRnWR 
Further company coverage:  KDNY.O 

 ((Reuters.Briefs@thomsonreuters.com;))